Order Article Reprints

McSorley LM, Tharmabala M, Al Rahbi F, Keane F, Evoy D, Geraghty JG, Rothwell J, McCartan DP, Greally M, O’Connor M, et al. Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland. Current Oncology. 2024; 31(3):1302-1310. https://doi.org/10.3390/curroncol31030098

McSorley, Lynda M., Mehala Tharmabala, Fathiya Al Rahbi, Fergus Keane, Denis Evoy, James G. Geraghty, Jane Rothwell, Damian P. McCartan, Megan Greally, Miriam O’Connor, and et al. 2024. "Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland" Current Oncology 31, no. 3: 1302-1310. https://doi.org/10.3390/curroncol31030098

McSorley, L. M., Tharmabala, M., Al Rahbi, F., Keane, F., Evoy, D., Geraghty, J. G., Rothwell, J., McCartan, D. P., Greally, M., O’Connor, M., O’Mahony, D., Keane, M., Kennedy, M. J., O’Reilly, S., Millen, S. J., Crown, J. P., Kelly, C. M., Prichard, R. S., Quinn, C. M., & Walshe, J. M. (2024). Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland. Current Oncology, 31(3), 1302-1310. https://doi.org/10.3390/curroncol31030098